Focal and temporal regulation of TrkB gene expression in chick auditory brainstem

鸡听觉脑干 TrkB 基因表达的局灶性和时间性调节

基本信息

  • 批准号:
    8091892
  • 负责人:
  • 金额:
    $ 23.92万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-05-01 至 2013-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The chick auditory system is similar to that in mammals and has served as a valuable research tool in the study of sound processing, neural circuit development and degeneration for the past 40 years, mainly because of its accessibility throughout development. Until recently the tools to make genetic manipulations in the system, either gene overexpression or knockdown, have been limited mostly to early embryonic times. Recently transposon-based vectors have been shown to express in chick. The advantage of these vectors is that they integrate into the chick genome when introduced by in ovo electroporation at E2 and can be regulated in a temporal manner, meaning the genes are integrated at E2 but not expressed until the desired time. TrkB, the growth factor receptor that binds the neurotrophin BDNF, has an interesting and unique expression pattern in the two brainstem auditory nuclei, nucleus magnocellularis (NM) and nucleus laminaris (NL). NL is a laminar layer of bidentate neurons receiving excitatory input dorsally from ipsilateral NM axons, and ventrally from contralateral NM processes. From the start of synaptogenesis, TrkB expression increases in NL, segregates to the ventral dendrites, and remains there through hatching. In central neurons in mammals TrkB is crucial for dendrite growth, arborization and maintenance of synapses. Many of these studies have been done on neurons in culture, far fewer in vivo in transgenic animals, and without the fine temporal ability to regulate expression in specific cells. In addition, there are 2 major isoforms of TrkB and both are present in mammals and in the chick brainstem. We propose to exploit the use of transposon-based vectors in the chick to regulate TrkB isoform expression at specific times in development to dissect their roles in cell migration, dendritogenesis, synaptogenesis, and the refinement and maintenance of NM/NL synaptic connections. The Tol2-doxycycline regulated vectors reported by Sato et al. (2007) will be used with a TrkB-shRNA-mir30 expression cassette to regulate TrkB isoform knockdown. The techniques pioneered here, stable integration and temporal regulation of shRNA expression and TrkB gene expression at later embryonic stages in specific cells will be of great use others who study mid to late developmental processes in chick embryos. PUBLIC HEALTH RELEVANCE: The auditory circuit of the chick is similar to that in mammals and much more accessible to study, yet until recently the techniques to understand the molecular basis of development and degeneration of the system have been lacking in the chick. We will use a newly developed gene expression system to temporally regulate important molecules in specific cells in the chick auditory system to access their roles in the development and maintenance of proper neural connections
描述(由申请人提供):小鸡的听觉系统与哺乳动物的听觉系统相似,在过去的40年里,小鸡的听觉系统一直是研究声音处理、神经回路发育和退化的有价值的研究工具,这主要是因为小鸡的听觉系统在整个发育过程中都是可接近的。直到最近,在系统中进行基因操作的工具,无论是基因过表达还是基因敲减,都主要限于早期胚胎时期。最近转座子载体已被证明在鸡中表达。这些载体的优点是,当在E2通过卵内电穿孔引入时,它们整合到鸡基因组中,并且可以以时间方式调节,这意味着基因在E2整合,但直到所需的时间才表达。TrkB是与神经营养因子BDNF结合的生长因子受体,在脑干的两个听觉核团(大细胞核(NM)和板状核(NL))中具有有趣且独特的表达模式。NL是一个层状的双齿神经元,从同侧NM轴突背侧接受兴奋性输入,从对侧NM过程腹侧接受兴奋性输入。从突触发生开始,TrkB表达增加NL,分离到腹侧树突,并通过孵化保持在那里。在哺乳动物的中枢神经元中,TrkB对于树突生长、树枝化和突触的维持至关重要。这些研究中有许多是在培养的神经元上进行的,在转基因动物体内进行的研究要少得多,而且没有在特定细胞中调节表达的精细时间能力。此外,TrkB有2种主要的同种型,两者都存在于哺乳动物和鸡脑干中。我们建议利用转座子为基础的载体在小鸡调节TrkB亚型的表达在特定的时间在发展中剖析他们的作用,细胞迁移,树突状细胞,突触,和细化和维护NM/NL突触连接。由Sato等人(2007)报道的Tol 2-强力霉素调节的载体将与TrkB-shRNA-mir 30表达盒一起使用以调节TrkB同种型敲低。在此开创的技术,稳定的整合和时间调控的shRNA表达和TrkB基因表达在胚胎后期的特定细胞将是非常有用的其他人谁研究中晚期发育过程中的鸡胚。 公共卫生相关性:小鸡的听觉回路与哺乳动物的听觉回路相似,更容易研究,但直到最近,在小鸡中一直缺乏了解该系统发育和退化的分子基础的技术。我们将使用一个新开发的基因表达系统来暂时调节鸡听觉系统中特定细胞中的重要分子,以评估它们在正常神经连接的发育和维持中的作用

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARK ALLEN BOTHWELL其他文献

MARK ALLEN BOTHWELL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARK ALLEN BOTHWELL', 18)}}的其他基金

Focal and temporal regulation of TrkB gene expression in chick auditory brainstem
鸡听觉脑干 TrkB 基因表达的局灶性和时间性调节
  • 批准号:
    8261871
  • 财政年份:
    2011
  • 资助金额:
    $ 23.92万
  • 项目类别:
Nogo Receptor Signaling and Function
Nogo 受体信号传导和功能
  • 批准号:
    7161720
  • 财政年份:
    2004
  • 资助金额:
    $ 23.92万
  • 项目类别:
Nogo Receptor Signaling and Function
Nogo 受体信号传导和功能
  • 批准号:
    6828212
  • 财政年份:
    2004
  • 资助金额:
    $ 23.92万
  • 项目类别:
Nogo Receptor Signaling and Function
Nogo 受体信号传导和功能
  • 批准号:
    6705603
  • 财政年份:
    2004
  • 资助金额:
    $ 23.92万
  • 项目类别:
Nogo Receptor Signaling and Function
Nogo 受体信号传导和功能
  • 批准号:
    6998453
  • 财政年份:
    2004
  • 资助金额:
    $ 23.92万
  • 项目类别:
Amyloid Precursor Protein Signaling
淀粉样蛋白前体蛋白信号转导
  • 批准号:
    6934485
  • 财政年份:
    2002
  • 资助金额:
    $ 23.92万
  • 项目类别:
Amyloid Precursor Protein Signaling
淀粉样蛋白前体蛋白信号转导
  • 批准号:
    6530492
  • 财政年份:
    2002
  • 资助金额:
    $ 23.92万
  • 项目类别:
Amyloid Precursor Protein Signaling
淀粉样蛋白前体蛋白信号转导
  • 批准号:
    6787714
  • 财政年份:
    2002
  • 资助金额:
    $ 23.92万
  • 项目类别:
Amyloid Precursor Protein Signaling
淀粉样蛋白前体蛋白信号转导
  • 批准号:
    7118087
  • 财政年份:
    2002
  • 资助金额:
    $ 23.92万
  • 项目类别:
Amyloid Precursor Protein Signaling
淀粉样蛋白前体蛋白信号转导
  • 批准号:
    6655057
  • 财政年份:
    2002
  • 资助金额:
    $ 23.92万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 23.92万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 23.92万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 23.92万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.92万
  • 项目类别:
    Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 23.92万
  • 项目类别:
    Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 23.92万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 23.92万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
  • 批准号:
    10639161
  • 财政年份:
    2023
  • 资助金额:
    $ 23.92万
  • 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
  • 批准号:
    10752441
  • 财政年份:
    2023
  • 资助金额:
    $ 23.92万
  • 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
  • 批准号:
    10867639
  • 财政年份:
    2023
  • 资助金额:
    $ 23.92万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了